From the Department of Radiology and Neuroradiology (V.C.K., C.R., S.J.E., H.H.S., E.H.), University Hospital Bonn, Bonn, Germany
Institute for Diagnostic and Interventional Neuroradiology (M.W.-M.), University Hospital Würzburg, Würzburg, Germany.
AJNR Am J Neuroradiol. 2017 Oct;38(10):1892-1898. doi: 10.3174/ajnr.A5313. Epub 2017 Aug 10.
The occurrence of medulloblastomas in adults is rare; nevertheless, these tumors can be subdivided into genetic and histologic entities each having distinct prognoses. This study aimed to identify MR imaging biomarkers to classify these entities and to uncover differences in MR imaging biomarkers identified in pediatric medulloblastomas.
Eligible preoperative MRIs from 28 patients (11 women; 22-53 years of age) of the Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults (NOA-7) cohort were assessed by 3 experienced neuroradiologists. Lesions and perifocal edema were volumetrized and multiparametrically evaluated for classic morphologic characteristics, location, hydrocephalus, and Chang criteria. To identify MR imaging biomarkers, we correlated genetic entities () wild type, (), and nonnon medulloblastomas (in adults, Group 4), and histologic entities were correlated with the imaging criteria. These MR imaging biomarkers were compared with corresponding data from a pediatric study.
There were 19 wild type (69%), 4 -activated (14%), and 5 Group 4 (17%) medulloblastomas. Six potential MR imaging biomarkers were identified, 3 of which, hydrocephalus ( = .03), intraventricular macrometastases ( = .02), and hemorrhage ( = .04), when combined, could identify medulloblastoma with 100% sensitivity and 88.3% specificity (95% CI, 39.8%-100.0% and 62.6%-95.3%). -activated nuclear β-catenin accumulating medulloblastomas were smaller than the other entities (95% CI, 5.2-22.3 cm versus 35.1-47.6 cm; = .03). Hemorrhage was exclusively present in nonnon medulloblastomas ( = .04; = 2/5). MR imaging biomarkers were all discordant from those identified in the pediatric cohort. Desmoplastic/nodular medulloblastomas were more rarely in contact with the fourth ventricle (4/15 versus 7/13; = .04).
MR imaging biomarkers can help distinguish histologic and genetic medulloblastoma entities in adults and appear to be different from those identified in children.
成人中髓母细胞瘤的发生较为罕见,但这些肿瘤可分为具有不同预后的遗传和组织学实体。本研究旨在确定磁共振成像标志物,以对这些实体进行分类,并揭示在儿科髓母细胞瘤中发现的磁共振成像标志物的差异。
对多中心成人髓母细胞瘤治疗试验(NOA-7)队列中 28 例患者(11 名女性;22-53 岁)的 28 例术前磁共振成像进行评估,由 3 名有经验的神经放射科医生进行评估。对病变和周围水肿进行容积测量,并对典型形态学特征、位置、脑积水和 Chang 标准进行多参数评估。为了确定磁共振成像标志物,我们将遗传实体(野生型、)和非髓母细胞瘤(成人组 4)与组织学实体相关联,并将影像学标准与组织学实体相关联。将这些磁共振成像标志物与儿科研究的相应数据进行比较。
19 例为野生型(69%)、4 例 -激活型(14%)和 5 例组 4(17%)髓母细胞瘤。确定了 6 个潜在的磁共振成像标志物,其中 3 个标志物(脑积水、脑室内部大转移和出血)联合使用时,可在 100%的敏感度和 88.3%的特异性(95%置信区间,39.8%-100.0%和 62.6%-95.3%)下识别髓母细胞瘤。-激活的核 β-连环蛋白蓄积性髓母细胞瘤小于其他实体(95%置信区间,5.2-22.3cm 与 35.1-47.6cm;=0.03)。仅在非髓母细胞瘤中发现出血(=0.04;=2/5)。磁共振成像标志物均与儿科队列中确定的标志物不一致。黏液样/结节性髓母细胞瘤与第四脑室接触较少(4/15 与 7/13;=0.04)。
磁共振成像标志物有助于区分成人组织学和遗传学髓母细胞瘤实体,且似乎与儿科患者不同。